For more information, visit www.avient.com.   To access Avient’s news library online, please visit www.avient.com/news. Media Relations Contacts

For more information, visit www.avient.com/ # # http://www.avient.com/investors https://edge.media-server.com/mmc/p/edkwvu9r https://edge.media-server.com/mmc/p/edkwvu9r http://www.avient.com/investors https://www.avient.com/ 4 Forward-looking Statements In this press release, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Investor Relations Contact: Giuseppe (Joe) Di Salvo Vice President, Treasurer and Investor Relations Avient Corporation +1 440-930-1921 giuseppe.disalvo@avient.com Media Contact: Kyle G.

BA B Y B OT T L E M A N U FAC T U R E R I N F A N T M I L K B O T T L E S • Compliant with FDA food contact and China National Standard GB 9685 • Able to withstand repeated steam sterilization • Transparent for more pleasing appearance and easy identification of measurement lines • Good impact resistance • Developed formulation to comply with both FDA and GB 9685 • Provided material able to withstand repeated steam sterilization and maintain excellent mechanical performance • Achieved a more pleasing color and clarity to enhance measurement lines • Met the need for impact resistance Colorant Chromatics™ PPSU Precolor KEY REQUIREMENTS WHY AVIENT? Modified PPSU Neat PPSU https://www.avient.com/products/polymer-colorants/high-temperature-color-concentrates/colorant-chromatics-pes/psu/ppsu-color-concentrates-0

Microsoft PowerPoint - Avient March IR - Fermium AVIENT CORPORATION (NYSE: AVNT) M A R C H 1 8 , 2 0 2 1 I R M E E T I N G S H O S T E D B Y F E R M I U M R E S E A R C H D I S C L A I M E R 2 Forward-Looking Statements In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These investments also consider our global footprint, and we are positioned very well and strategically from a regional perspective. 8 Growth Drivers 2020 Revenue ($ Millions) Long-Term Growth Rate Sustainable Solutions $ 560 8–12% Healthcare 555 8–10% Composites / 5G 212 10% Growth in Emerging Regions 672 5% Other (GDP growth) 1,784 2–3% Pro Forma Avient $ 3,783 6.5% 2 0 2 0 P E R F O R M A N C E 2020 HIGHLIGHTS 10 • Completed transformational Clariant Masterbatch acquisition and created new brand name Avient • Increased pro forma adjusted EPS 11% from $1.74 to $1.93 as an essential supplier during the pandemic and due to growth in demand for consumer applications • Specialty Engineered Materials delivered record operating income on gains from composites • Achieved record free cash flow, increased dividend for 10th year in a row and delevered from 3.5x to 2.7x net debt to pro forma adjusted EBITDA • Culture is everything: Certified as a Great Place to Work® $133 $150 2019PF 2020PF 10% 23%8% 21% 4% 15% 2006 2020PF Healthcare Consumer Packaging Avient Portfolio Transformation 22% 59% CLARIANT MASTERBATCH: TRANSFORMATIONAL ACQUISITION 11 Clariant MB EBITDA Growth Purchase Price Multiple 10.8 9.6 6.5 2019PF 2020PF 2020PF w/ Full Synergies x x x • Acquisition of Clariant Masterbatch significantly expands presence in healthcare, packaging and consumer end markets • Strength of portfolio – 13% EBITDA growth as an essential supplier in COVID response and recovery • Acquisition completed on July 1, 2020 for $1.4 billion. SEGMENT HIGHLIGHTS U.S. & Canada 50% EMEA 26% Asia 16% Latin America 8% 2020 SEGMENT, END MARKET AND GEOGRAPHY 29 GEOGRAPHY REVENUESEGMENT FINANCIALS Consumer 23% Packaging 21%Industrial 15% Wire & Cable 6% Building & Construction 6% Electrical & Electronics 4% END MARKET REVENUE Transportation 10% Healthcare 15% All data reflects 2020 Pro forma for acquisition of the Clariant Masterbatch business. (1) The total company sales and EBITDA of $3,783M and $457M, respectively, include intercompany sales eliminations and corporate costs $2,043M $331M $709M $124M $1,110M $70M Sales EBITDA Distribution Specialty Engineered Materials Color Additives and Inks $457M$3,783M (1) Packaging 35% Consumer 23% Healthcare 8% Industrial 14% Building & Construction 8% Transportation 7% Wire & Cable 3% Electrical & Electronics 2% C O L O R , A D D I T I V E S & I N K S 2 0 2 0 P F R E V E N U E | $ 2 . 0 B I L L I O N US & Canada 31% EMEA 40% Asia 22% Latin America 7% END MARKET REGION 30 2020 figures Pro forma for acquisition of the Clariant Masterbatch business S P E C I A L T Y E N G I N E E R E D M A T E R I A L S Consumer 24% Healthcare 10% Packaging 6% Wire & Cable(1) 24% Electrical & Electronics 13% Transportation 11% Industrial 10% Building & Construction 2% 2 0 2 0 R E V E N U E | $ 7 0 9 M I L L I O N END MARKET US & Canada 58% EMEA 23% Asia 19% REGION 31 (1) Approximately 50% of Wire and Cable sales are associated with Fiber Optic Cabling D I S T R I B U T I O N 2 0 2 0 R E V E N U E | $ 1 . 1 B I L L I O N Healthcare 29% Consumer 25% Packaging 2% Industrial 20% Transportation 14% Electrical & Electronics 5% Building & Construction 4% Wire & Cable 1% US & Canada 82% Asia 3% Latin America 15% END MARKET REGION K E Y S U P P L I E R S 32 AMERICAS EMEA ASIA Consumer 26% Healthcare 19% Packaging 13% Industrial 16% Wire & Cable 7% Building & Construction 5% Electrical & Electronics 4% Packaging 34% Consumer 16%Healthcare 5% Industrial 17% Wire & Cable 10% Building & Construction 8% Electrical & Electronics 3% Packaging 32% Consumer 27% Healthcare 12% Industrial 6% Wire & Cable 6% Building & Construction 4% Electrical & Electronics 9% Transportation 10% Transportation 7% Transportation 4% 2020 figures Pro forma for acquisition of the Clariant Masterbatch business T O T A L C O M PA N Y R E G I O N A L S A L E S B Y E N D M A R K E T (58% of sales) (26% of sales) (16% of sales) 33

For more information, visit www.avient.com. To access Avient's news library online, please visit www.avient.com/news Media Relations Contacts

These customizable formulations can replace traditional materials such as FR PC/ABS, FR PC/PET and FR COPE, offer improved chemical resistance to common disinfectants, achieve a UL 94 V-0 at 1.5 & V-1 at 0.75 flame rating when necessary, and can often be molded in existing PC/ABS tooling. Chemically resistant replacement for FR PC/ABS, FR PC/PET & FR COPE providing UL 94 Yellow Card V-0 flame rating at 1.5 mm, V-1 at 0.75 mm thicknesses for a broad color spectrum Avient's TPEs and engineered materials for auto-injector pens offer excellent chemical and impact resistance, good self-lubrication functions, durability to extend product life, and compliance with biocompatibility and food-contact safety regulations. 

COLORANT CHROMATICS HIGH-TEMPERATURE POLYMER FORMULATIONS PRODUCT SELECTION GUIDE COLORANT CHROMATICS HIGH TEMPERATURE COMPOUNDS PROPERTY ISO Test Method Units PES PPSU PEI LCP PEEK PSU PHYSICAL Density 1183 — 1.37 1.29 1.27 1.40 1.30 1.24 Mold Shrinkage Flow/X-flow 294–4 % 0.8/0.85 0.7/XX 0.6/0.7 0/0.7 1.0/1.3 0.7 MECHANICAL Tensile Strength 527 Mpa 85 70 85 200 100 70 Tensile Elongation Yield 527 % 7 7.5 6 — — 6 Tensile Elongation Break 527 % >25 >60 60 3 30 >50 Izod Notched 180 kJ/m2 7 55 5 95 7 5.5 THERMAL HDT 1.8 MPa 75 °C 205 200 190 190 150 175 FLAMMABILITY Flame Rating UL-94 — V-0 V-0 V-0 V-0 V-0 HB ADDITIONAL Steam Sterilizable — Cycles 100 2000 2000 1500 1000 100 CUSTOM OPTIONS Color — — Yes Yes Yes Yes Yes Yes Reinforced — — Yes Yes Yes Yes Yes Yes Conductive — — Yes Yes Yes Yes Yes Yes Lubricated — — Yes Yes Yes No Yes Yes Radiopaque — — Yes Yes Yes No Yes Yes Trade Names — — Veradel Ultrason E Radel Ultrason P Ultem Vectra Zenite Xydar KetaSpire Victrex Vestakeep Udel Ultrason S Avient high temperature precolored and specialty compounds are your solutions for high performance products. KEY FEATURES • High temperature resistance • Biocompatible • Brilliant colors • Multi sterilizable • Hydrolytic stability • Chemical resistance • Flame resistance • High mechanical performance • Food contact compliant APPLICATIONS • FDA medical & dental devices • Sterilization trays • Aircraft interiors • Automotive lighting • Chemical handling • Sensors and pumps • Plumbing fittings & manifolds • Food service trays • Gears & bushings • Membranes • Connectors For more information, email info.colorant.chromatics@avient.com or call +1.860.626.3029 1.844.4AVIENT www.avient.com Copyright © 2021, Avient Corporation.

http://www.avient.com/investors https://edge.media-server.com/mmc/p/k7okojz2 https://edge.media-server.com/mmc/p/k7okojz2 http://www.avient.com/investors 4 About Avient Avient Corporation (NYSE: AVNT), with 2021 revenues of $4.8 billion, provides specialized and sustainable material solutions that transform customer challenges into opportunities, bringing new products to life for a better world. For more information, visit www.avient.com Investor Relations Contact: Giuseppe (Joe) Di Salvo Vice President, Treasurer and Investor Relations Avient Corporation +1 440-930-1921 giuseppe.disalvo@avient.com Media Contact: Kyle G.

Evaluation showed an increase in circulation and blood flow velocity after body contacts with warmed fabric. TEMPERATURE DISTRIBUTION DIAGRAM • Test Method: FTTS-FA-010-2007 4.2 • Equipment: Thermovision • Heat Source: 500W Halogen Lamp • Heat Distance: 100 cm Surface temperature before exposure: 20.22°C Surface temperature after 10 min exposure: 33.85°C Temperature change: +13.6°C Added Cesa Fiber Additives for heat preservation TEST METHOD STANDARD REQUEST TEST RESULT GB/T30127 Far infrared radiation properties Far infrared emissivity ≥0.88 (5-14um) (Test temperature: 34°C) 0.9 Far infrared radiation temperature rise ≥ 1.4°C 9°C GB/T 18319-2019 Thermal retention with accumulated by infrared ray Maximum temperature rise ≥ 6°C 8.9°C Mean temperature rise ≥ 4.4°C (20 minutes) 5.6°C FTTS-FA-010 Infrared radiation properties & thermal retention temperature rise Average emissivity ≥ 0.8 (2-22um) (Test temperature: 25°C) 0.8 Specified heating ΔT ≥ 0.5°C (relative to the standard) +5.34°C (ΔT) GB/T 11048-2008 Method A Thermal transmittance Unit: clo Naked body: 0 Underwear: 0.04 T-shirt: 0.09 Thick sweater: 0.35 Winter coat: 0.7 All the data above are the reference value 0.625 Human Physiological Experiment Blood flow volume +12.9% Blood flow velocity +13.6% Blood oxygenation(%SpO2) +1.7% www.avient.com Copyright © 2023, Avient Corporation. Contact your Avient representative to find out about availability in your country or region.

This formulation provided both the processability required for extremely short cycle injection-compression molding, as well as including an additive to stabilize the material when in contact with copper. This additive will protect the door from cracking as it comes into contact with copper particles over time. PSIC: 0 2.